NOVOCURE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.15 USD | -4.24% |
|
+0.64% | +48.36% |
| Jun. 04 | Wedbush Adjusts Price Target on NovoCure to $24 From $21, Maintains Neutral Rating | MT |
| Jun. 03 | Novocure Announces the Presentation of Clinical Data from the Phase 3 Metis Trial | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 24.05 | 24.05 | 31.24 |
| Spread/Res. | -7.90% | -7.90% | -29.10% |
| Spread/Supp. | +28.11% | +28.11% | +99.01% |
| Support | 17.29 | 17.29 | 11.13 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NVCR Stock
- Charts NovoCure Limited
